Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Kidney Cancer (Clifton, Va.)|October 19, 2018
Translating Metabolic Reprogramming into New Targets for Kidney CancerOmran Abu Aboud, Robert H WeissClinical Chemistry|November 15, 2012
New opportunities from the cancer metabolomeOmran Abu Aboud, Robert H WeissPlos One|August 17, 2013
Inhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cellsOmran Abu Aboud, Hiromi I Wettersten, Robert H WeissNature Reviews. Nephrology|May 9, 2017
Metabolic reprogramming in clear cell renal cell carcinomaHiromi I Wettersten, Omran Abu Aboud, Primo N Lara, et al.Molecular Cancer Therapeutics|July 9, 2016
Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer GrowthOmran Abu Aboud, Ching-Hsien Chen, William Senapedis, et al.American Journal of Physiology. Cell Physiology|March 27, 2015
PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growthOmran Abu Aboud, Dallas Donohoe, Scott Bultman, et al.ERJ Open Research|March 6, 2024
Heated tobacco product IQOS induces unique metabolic signatures in human bronchial epithelial cellsErin O Curley, Omran Abu Aboud, Kenneth J Chmiel, et al.Cancer Research|October 13, 2017
Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time ImagingOmran Abu Aboud, Samy L Habib, Josephine Trott, et al.Cancer Research|May 26, 2012
Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysisSheila Ganti, Sandra L Taylor, Omran Abu Aboud, et al.Kidney360|February 28, 2022
Anti-Cancer Activity of PAK4/NAMPT Inhibitor and Programmed Cell Death Protein-1 Antibody in Kidney CancerJosephine F Trott, Omran Abu Aboud, Bridget McLaughlin, et al.Pageof 2